Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-890
Closed -$217K 22
2021
Q2
$217K Sell
890
-1
-0.1% -$246 0.46% 23
2021
Q1
$222K Buy
+891
New +$213K 0.19% 58
2020
Q4
Sell
-979
Closed -$249K 100
2020
Q3
$249K Hold
979
0.17% 92
2020
Q2
$231K Buy
+979
New +$223K 0.17% 93
2020
Q1
Sell
-1,100
Closed -$264K 95
2019
Q4
$264K Sell
1,100
-5
-0.5% -$1.1K 0.18% 89
2019
Q3
$214K Sell
1,105
-50
-4% -$9.6K 0.16% 95
2019
Q2
$213K Sell
1,155
-130
-10% -$23.3K 0.16% 83
2019
Q1
$249K Buy
+1,285
New +$245K 0.19% 72

Other funds holding AMGN

RBA Wealth Management's AMGN Position: Q3 2021 in Review

RBA Wealth Management sold out of Amgen (AMGN) in Q3 2021, closing a stake of 890 shares — an estimated $217K sold.

RBA Wealth Management first reported a position in AMGN in Q1 2019 and held it in 8 quarters. The position peaked at $264K in Q4 2019. 2,132 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

  • RBA Wealth Management reported no remaining Amgen position as of Q3 2021 after selling out during the quarter.
  • RBA Wealth Management sold 890 Amgen shares in Q3 2021, an estimated $217K.
  • RBA Wealth Management first reported a position in Amgen in Q1 2019 and held it in 8 quarters.
  • RBA Wealth Management's Amgen position peaked at $264K in Q4 2019.
  • 2,132 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on RBA Wealth Management's 13F filing for Q3 2021, filed 15 Nov 2021.